EVerZom works towards the democratization of regenerative medicine, using biological sub-cellular tools – extracellular vesicles – which are considered as an efficient and safer alternative to cell therapies. EVerZom, a spin off from a CNRS/Paris University laboratory, has developed and patented an innovative process which enables a high yield, GMP compatible and fast-foward production of extracellular […]